Stocks and Investing
Stocks and Investing
Tue, March 1, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jason Cassorla Maintained (UHS) at Strong Buy with Increased Target to $167 on, Mar 1st, 2022
Jason Cassorla of Citigroup, Maintained "Universal Health Services, Inc." (UHS) at Strong Buy with Increased Target from $162 to $167 on, Mar 1st, 2022.
Jason has made no other calls on UHS in the last 4 months.
There are 5 other peers that have a rating on UHS. Out of the 5 peers that are also analyzing UHS, 3 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Joseph France of "Seaport Global" Downgraded from Strong Buy to Hold on, Monday, February 28th, 2022
- Sarah James of "Piper Sandler" Maintained at Hold with Increased Target to $145 on, Monday, February 28th, 2022
- Whit Mayo of "SVB Leerink" Maintained at Hold with Increased Target to $139 on, Monday, February 28th, 2022
These are the ratings of the 2 analyists that currently disagree with Jason
- Steven Valiquette of "Barclays" Maintained at Sell and Held Target at $145 on, Friday, February 25th, 2022
- Jamie Perse of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $135 on, Tuesday, November 9th, 2021
Contributing Sources